Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY)
US Markets
$13.60
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
About Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 7.2B | 8.6B | 8.4B | 8.1B |
| Gross Profit | 6.1B | 7.5B | 7.3B | 7.0B |
| Operating Income | 2.0B | 2.8B | 2.3B | 2.6B |
| Net Income | 1.9B | 2.6B | 2.0B | 2.3B |
| Diluted EPS | $0.60 | $nan | $nan | $0.68 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 21.3B | 22.8B | 28.0B | 31.6B |
| Gross Profit | 17.8B | 19.3B | 24.1B | 27.3B |
| Operating Income | 3.3B | 4.6B | 6.8B | 8.6B |
| Net Income | 3.9B | 4.3B | 6.3B | 7.7B |
| Diluted EPS | $1.22 | $1.36 | $2.00 | $2.36 |